🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

So great to have my friend Alexander P Cole at Yale Urology to talk about health disparities and climate change pertaining to urology. Phenomenal talk and very relevant to everyday practice

Such an honour to speak at the Distinguished Plenary Session at DDW San Diego 2025 and to meet the legends in the field of Barrett's oesophagus and oesophageal cancer

⚡️ FDA analysis in metastatic RCC: Cytoreductive nephrectomy before ICI + VEGFi was associated with: ✔️ Longer OS (46 vs. 28 months) ✔️ Improved PFS and ORR Retrospective, hypothesis-generating—but clinically relevant. academic.oup.com/jnci/article/1… #KidneyCancer #Immunotherapy

Consolidative local therapy in metastatic #BladderCancer after systemic treatment response. Fed Ghali Yale Urology joins Sam S. Chang MD, MBA Vanderbilt Urology in this discussion of the role of consolidative local therapy in metastatic bladder cancer patients who show robust responses to

We did it!! I am really honoured to lead this important FIH study! A novel transurethral robotic system that can make ERBT much easier, and hopefully we can generalize the technique to every urologist globally. A better surgery will lead to better outcomes!! 🌎 #UroSoMe

This is great to see - too often are patients starved for too long before their procedures.

I feel truly honoured to lead this important first-in-human trial using the Virtuoso Robotic System for something that is very close to my heart - En bloc resection of bladder tumour. #UroSoMe (1/n) youtu.be/gTUv-cq-ICI?si…

We are looking for an associate research scientist and lab manager for our translational cancer immunology lab at Yale. Please email ([email protected]) or DM me to apply. Full information about the job and the requirements can be found here: jobrxiv.org/job/yale-schoo… Pls RT!

What if this was a drug ?🙂 🆕 NEJM | June 2025 🎯 CHALLENGE Trial: Structured exercise after adjuvant chemo in colon cancer 📦 RCT | n=889 | Median FU: 7.9 yrs 🟠 3-yr structured aerobic program vs health ed alone 📈 Primary Endpoint: Disease-Free Survival (DFS) 🔹 HR 0.72

The International Bladder Cancer Group (IBCG) is pleased to announce the #IBCG2025 Travel Award, designed to support outstanding fellows and early-career academic faculty who are committed to advancing the field of bladder cancer. For more information and to apply:

📰👀Finger test ‘has no role in diagnosing prostate cancer today’ We, alongside Prostate Cancer UK, have united in calling for an end to the routine use of the digital rectal examination, with it no longer being a useful test for #ProstateCancer Via The Times and The Sunday Times: thetimes.com/uk/healthcare/…

Our take on radiation for NMIBC in European Urology Saum Ghodoussipour Melinda Fu authors.elsevier.com/a/1lFCk14kpm0h…

A 🧵 on our recent study on surveillance for IR-NMIBC European Urology Oncology authors.elsevier.com/c/1l7pU_wtP00L… There is limited evidence on follow-up for IR-NMIBC. We used data from >2000 primary Ta–T1 NMIBC to stratify IR-NMIBC by recurrence risk and propose a risk-adapted follow-up approach.

🚨 NEW #PlatinumOpinion in European Urology by M. J. Roberts, Giorgio Gandaglia et al : 💡 Is extended pelvic lymph node dissection (ePLND) still justified in prostate cancer? 📉 No oncologic benefit in RCTs ⚠️ Up to 20% complication rate 🧬 PSMA PET reshapes staging 🔄 2024 EAU

New data on hydro TMT in MIBC 🚨guess that’s why it’s not ideal 👎 📊 74% of patients with pre-existing hydronephrosis still had it post-TMT 💧 21% of patients WITHOUT hydronephrosis developed it after TMT 🧵 52% of new cases needed PCNT drainage…. rdcu.be/ethqd

1/8 🎉Thrilled to share our landmark study now published in The Lancet on a capsule sponge surveillance strategy for Barrett's oesophagus thelancet.com/journals/lance… presented at the BSG, Glasgow Cambridge University Early Cancer Institute, University of Cambridge Addenbrooke's Cancer Research UK Rebecca Fitzgerald Lab

🚨 NEW in #EuropeanUrology By Saum Ghodoussipour Roger Li Sarah P. Psutka MD MS Trinity J. Bivalacqua Joan Palou Redorta et al Can novel intravesical therapies change the game for non–muscle-invasive bladder cancer? This systematic review explores: ✅ BCG-based combos ✅ Gene & immune therapies ✅ Innovative drug

Chech out our study on TMT vs. RC for #MIBC a (long) 🧵(with some stats) sciencedirect.com/science/articl… Critical Reviews in Oncology Hematology (CROH) Daniele Robesti Ploussard Guillaume Giuseppe Fallara University of Cincinnati Cancer Center OncoAlert OncLive SOSS European Association of Urology (EAU) EAU guidelines Amer. Urol. Assn. Society of Urologic Oncology

🩸💥 Many have asked: “Where did the EAU #thromboprophylaxis guideline go?” Don’t worry. Check out cluevte.org 🚀 ✅ Not just #urology, also #gynecology & abd #surgery ✅ Procedure-specific VTE & bleeding risks ✅ Free interactive tool + static infographics #EBM

J&J receives U.S. FDA Priority Review for TAR-200 in high-risk NMIBC Phase 2b SunRISe-1 study #AUA25 ✅82.4 % CR rate ☑️ 52.9 % cancer-free at least one year after CR jnj.com/media-center/p…